Skip to main content
    Z

    Zoetis Inc (ZTS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $84.42
    +0.61 (+0.72%)

    Market Cap: $34.06B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Zoetis Inc (ZTS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Zoetis are Teva Pharma Industries Ltd ADR (TEVA), Viatris (VTRS) and United Therapeutics (UTHR). Zoetis trades at 12.7x earnings, against a median of 21.8x for the 10 of these companies with a P/E. By market cap, Zoetis ranks 4th of the 13 companies on this page; Takeda Pharmaceutical Co Ltd ADR (TAK) is the largest at $68.47B.

    Peer Comparison

    ZTS's ROIC of 21.7% is above the peer median of 5.7%, and its revenue growth of -1.3% is below the median of 6.5%. It yields 2.51%, while the median peer pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Zoetis (ZTS)$34.06B12.7x3.7x26.4%21.7%-1.3%2.51%
    Teva Pharma Industries Ltd ADR (TEVA)$51.92B14.4x2.9x2.9%4.3%-1.9%0.00%
    Viatris Inc (VTRS)$23.87B8.1x1.6x-4.1%-0.2%-0.3%2.31%
    United Therapeutics Corporation (UTHR)$25.18B22.2x7.9x38.6%N/A4.1%0.00%
    Takeda Pharmaceutical Co Ltd ADR (TAK)$68.47BN/A2.3x0.9%5.6%6.7%2.92%
    Elanco Animal Health (ELAN)$13.39B23.2x2.6x-2.9%1.6%11.3%0.00%
    Haleon plc (HLN)$40.25BN/A1.6x14.5%13.9%2.2%2.12%
    Neurocrine Biosciences Inc (NBIX)$16.94B18.4x4.5x19.0%N/A41.2%0.00%
    Dr. Reddy’s Laboratories Ltd ADR (RDY)$12.29B39.6x3.5x8.5%5.7%-1.5%0.44%
    Phibro Animal Health Corporation (PAHC)$1.46B10.7x0.9x6.7%11.7%6.3%1.37%
    Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)$7.45B21.4x2.2x4.2%11.6%10.0%0.00%
    Xeris Pharmaceuticals Inc (XERS)$3.04B139.2x8.2x-1.8%15.5%44.2%0.00%
    Kiniksa Pharmaceuticals Ltd (KNSA)$7.57B72.5x7.8x11.6%N/A58.1%0.00%
    Peer median$15.16B21.8x2.7x5.4%5.7%6.5%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Zoetis, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.

    CompanyAboutPeers
    Teva Pharma Industries Ltd ADR (TEVA)
    Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs...
    TEVA competitors
    Viatris Inc (VTRS)
    Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.
    VTRS competitors
    United Therapeutics Corporation (UTHR)
    United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs...
    UTHR competitors
    Takeda Pharmaceutical Co Ltd ADR (TAK)
    Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals...
    TAK competitors
    Elanco Animal Health (ELAN)
    Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures and markets products for pets and farm animals.
    ELAN competitors
    Haleon plc (HLN)
    Haleon plc (HLN) is a leading global consumer health company, emerging as a spin-off from GlaxoSmithKline...
    Neurocrine Biosciences Inc (NBIX)
    Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological...
    NBIX competitors
    Dr. Reddy’s Laboratories Ltd ADR (RDY)
    Dr. Reddy's Laboratories Limited is a globally integrated pharmaceutical company. The company is headquartered in Hyderabad, India.
    RDY competitors
    Phibro Animal Health Corporation (PAHC)
    Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily...
    PAHC competitors
    Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)
    Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms...
    AMRX competitors
    Xeris Pharmaceuticals Inc (XERS)
    Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations.
    XERS competitors
    Kiniksa Pharmaceuticals Ltd (KNSA)
    Kiniksa Pharmaceuticals Ltd. (KNSA) is an innovative biopharmaceutical company focused on developing breakthrough therapies to address pressing unmet medical...
    KNSA competitors

    Frequently Asked Questions About ZTS

    Who are Zoetis' main competitors?

    The companies most similar to Zoetis include Teva Pharma Industries Ltd ADR (TEVA), Viatris (VTRS), United Therapeutics (UTHR), Takeda Pharmaceutical Co Ltd ADR (TAK) and Elanco Animal Health (ELAN), listed from the closest match.

    Who is Zoetis' biggest competitor?

    Takeda Pharmaceutical Co Ltd ADR (TAK) is the largest of the similar companies at $68.47B; Teva Pharma Industries Ltd ADR (TEVA) is the closest match by business profile, size, sector and industry.

    How does ZTS stock compare with its competitors?

    ZTS' P/E is 12.7x against a peer median of 21.8x; its P/S is 3.7x against a peer median of 2.7x; its net margin is 26.4% against a peer median of 5.4%.

    Which of Zoetis' competitors pays a higher dividend?

    Zoetis has a forward dividend yield of 2.51%. Takeda Pharmaceutical Co Ltd ADR (TAK) has a higher forward dividend yield; Takeda Pharmaceutical Co Ltd ADR (TAK) has the highest at 2.92%.

    Is Zoetis bigger than its competitors?

    No. Zoetis is 4th by market cap among the 13 companies on this page; the largest is Takeda Pharmaceutical Co Ltd ADR (TAK) at $68.47B.